{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:23:50Z","timestamp":1785425030224,"version":"3.56.0"},"reference-count":131,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["R37AI148064"],"award-info":[{"award-number":["R37AI148064"]}]},{"award":["R37AI148064"],"award-info":[{"award-number":["R37AI148064"]}],"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The HIV-1 Env glycoprotein mediates both cell-free and cell-to-cell viral transmission and represents the primary target for protective humoral immune responses. Studies examining antibody neutralization of cell-free and cell-to-cell HIV transmission have found that cell-to-cell transmission is more resistant to neutralization. This resistance may be explained in part by antigenically distinct Env populations on virions and infected cells. Cell-surface Env may be more heterogeneous due to variations in cleavage, glycosylation, and conformational state. Nevertheless, the mechanisms that maintain antigenically distinct Env populations at the cell surface and on virions remain unclear, despite virion assembly occurring at the plasma membrane. In this focused review, we consider how Env endocytosis and recycling influence Env incorporation into virions and antibody recognition. We further consider how Env cleavage may influence trafficking and endocytic fate. Given the central role of Env\u2019s cytoplasmic tail in engaging endosomal trafficking pathways, we review emerging structural models of the CT and discuss how its organization, symmetry, and conformational flexibility may contribute to Env trafficking and intracellular sorting. We also discuss how heterogeneous Env populations may influence antibody susceptibility. Finally, we review therapeutic strategies, including combinatorial antibodies and small-molecule Env modulators, that may enhance antibody recognition of infected cells and virions.<\/jats:p>","DOI":"10.3390\/v18080811","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:36:13Z","timestamp":1784878573000},"page":"811","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV-1 Env Heterogeneity: Cleavage, Trafficking, and Antigenic Consequences for Virions and Infected Cells"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-7832","authenticated-orcid":false,"given":"Dania M.","family":"Figueroa Acosta","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-1566","authenticated-orcid":false,"given":"Sara","family":"Khaleeq","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony R.","family":"Valencia","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Mason","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-1997","authenticated-orcid":false,"given":"Benjamin K.","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/312763a0","article-title":"The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus","volume":"312","author":"Dalgleish","year":"1984","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/323725a0","article-title":"Induction of CD4-dependent cell fusion by the HTLV-III\/LAV envelope glycoprotein","volume":"323","author":"Lifson","year":"1986","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.72.6.4694-4703.1998","article-title":"CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization","volume":"72","author":"Sullivan","year":"1998","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: From in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3389\/fimmu.2017.01655","article-title":"Increasing the Clinical Potential and Applications of Anti-HIV Antibodies","volume":"8","author":"Hua","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.it.2014.08.007","article-title":"Antibody B cell responses in HIV-1 infection","volume":"35","author":"Mouquet","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20030648","article-title":"HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse","volume":"199","author":"Jolly","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Alvarez, R.A., Barr\u00eda, M.I., and Chen, B.K. (2014). Unique Features of HIV-1 Spread through T Cell Virological Synapses. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004513"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12977-018-0434-1","article-title":"HIV-1 cell-to-cell transmission and broadly neutralizing antibodies","volume":"15","author":"Dufloo","year":"2018","journal-title":"Retrovirology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1084\/jem.20131244","article-title":"Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission","volume":"210","author":"Malbec","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Reh, L., Magnus, C., Schanz, M., Weber, J., Uhr, T., Rusert, P., and Trkola, A. (2015). Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004966"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e02425-16","DOI":"10.1128\/JVI.02425-16","article-title":"Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs","volume":"91","author":"Li","year":"2017","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1128\/JVI.00915-10","article-title":"Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication","volume":"84","author":"Abram","year":"2010","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/58.1.19","article-title":"Evolutionary and immunological implications of contemporary HIV-1 variation","volume":"58","author":"Korber","year":"2001","journal-title":"Br. Med. Bull."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm0698-679","article-title":"A role for carbohydrates in immune evasion in AIDS","volume":"4","author":"Reitter","year":"1998","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111350","DOI":"10.1016\/j.jbc.2026.111350","article-title":"Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer","volume":"302","author":"Nawaz","year":"2026","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28014","DOI":"10.1073\/pnas.2000260117","article-title":"Visualization of the HIV-1 Env glycan shield across scales","volume":"117","author":"Berndsen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ringe, R.P., Colin, P., Ozorowski, G., Allen, J.D., Yasmeen, A., Seabright, G.E., Lee, J.H., Antanasijevic, A., Rantalainen, K., and Ketas, T. (2023). Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. PLoS Pathog., 19.","DOI":"10.1101\/2023.08.08.552396"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-019-1101-y","article-title":"Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET","volume":"568","author":"Lu","year":"2019","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e34271","DOI":"10.7554\/eLife.34271","article-title":"HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations","volume":"7","author":"Ma","year":"2018","journal-title":"eLife"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41586-023-06762-6","article-title":"HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes","volume":"623","author":"Li","year":"2023","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.1254426","article-title":"Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions","volume":"346","author":"Munro","year":"2014","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/360358a0","article-title":"Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60","volume":"360","author":"Hallenberger","year":"1992","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0092-8674(88)90487-4","article-title":"Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus","volume":"53","author":"McCune","year":"1988","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1128\/jvi.63.11.4670-4675.1989","article-title":"Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160","volume":"63","author":"Freed","year":"1989","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1128\/JVI.02765-12","article-title":"Proteolytic processing of the human immunodeficiency virus envelope glycoprotein precursor decreases conformational flexibility","volume":"87","author":"Haim","year":"2013","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e00597-20","DOI":"10.1128\/JVI.00597-20","article-title":"Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands","volume":"94","author":"Lu","year":"2020","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18256","DOI":"10.1073\/pnas.1314351110","article-title":"Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation","volume":"110","author":"Ringe","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/jvi.64.5.2337-2344.1990","article-title":"Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site","volume":"64","author":"Bosch","year":"1990","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/JVI.77.1.353-365.2003","article-title":"Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies","volume":"77","author":"Poignard","year":"2003","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e01369-20","DOI":"10.1128\/JVI.01369-20","article-title":"Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions","volume":"95","author":"Zhang","year":"2021","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e00148-20","DOI":"10.1128\/JVI.00148-20","article-title":"Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins","volume":"94","author":"Zou","year":"2020","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e01542-25","DOI":"10.1128\/jvi.01542-25","article-title":"Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection","volume":"100","author":"Acosta","year":"2026","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1128\/JVI.03299-12","article-title":"Reevaluation of the requirement for TIP47 in human immunodeficiency virus type 1 envelope glycoprotein incorporation","volume":"87","author":"Checkley","year":"2013","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Groppelli, E., Len, A.C., Granger, L.A., and Jolly, C. (2014). Retromer regulates HIV-1 envelope glycoprotein trafficking and incorporation into virions. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004518"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e0076722","DOI":"10.1128\/jvi.00767-22","article-title":"Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14(+) Late Endosomes and Lysosomes to Regulate Surface Levels in T-Cell Lines","volume":"96","author":"Hoffman","year":"2022","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e01893-17","DOI":"10.1128\/JVI.01893-17","article-title":"HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation","volume":"92","author":"Kirschman","year":"2018","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1073\/pnas.122696599","article-title":"Cell surface expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing regulated secretory granules","volume":"99","author":"Miranda","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Qi, M., Williams, J.A., Chu, H., Chen, X., Wang, J.J., Ding, L., Akhirome, E., Wen, X., Lapierre, L.A., and Goldenring, J.R. (2013). Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003278"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00255-23","DOI":"10.1128\/jvi.00255-23","article-title":"KIF16B Mediates Anterograde Transport and Modulates Lysosomal Degradation of the HIV-1 Envelope Glycoprotein","volume":"97","author":"Weaver","year":"2023","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e0087622","DOI":"10.1128\/jvi.00876-22","article-title":"Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4(+) T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines","volume":"96","author":"Hoffman","year":"2022","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1073\/pnas.1504174112","article-title":"A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions","volume":"112","author":"Qi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15773","DOI":"10.1074\/jbc.273.25.15773","article-title":"A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor","volume":"273","author":"Boge","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/viro.1997.8839","article-title":"Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family","volume":"238","author":"Ohno","year":"1997","journal-title":"Virology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1083\/jcb.145.5.923","article-title":"Molecular bases for the recognition of tyrosine-based sorting signals","volume":"145","author":"Bonifacino","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e0063123","DOI":"10.1128\/jvi.00631-23","article-title":"Tryptophan-based motifs in the LLP3 region of the HIV-1 envelope glycoprotein cytoplasmic tail direct trafficking to the endosomal recycling compartment and mediate particle incorporation","volume":"97","author":"Lerner","year":"2023","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/JVI.75.6.2982-2992.2001","article-title":"The Highly Conserved C-Terminal Dileucine Motif in the Cytosolic Domain of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Is Critical for Its Association with the AP-1 Clathrin Adapter","volume":"75","author":"Wyss","year":"2001","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-4690-8-37","article-title":"Mutagenesis of tyrosine and di-leucine motifs in the HIV-1 envelope cytoplasmic domain results in a loss of Env-mediated fusion and infectivity","volume":"8","author":"Bhakta","year":"2011","journal-title":"Retrovirology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1074\/jbc.M113.529339","article-title":"Unique Functional Properties of Conserved Arginine Residues in the Lentivirus Lytic Peptide Domains of the C-terminal Tail of HIV-1 gp41*","volume":"289","author":"Kuhlmann","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Anokhin, B., and Spearman, P. (2022). Viral and Host Factors Regulating HIV-1 Envelope Protein Trafficking and Particle Incorporation. Viruses, 14.","DOI":"10.3390\/v14081729"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e01825-21","DOI":"10.1128\/mbio.01825-21","article-title":"The HIV Env Glycoprotein Conformational States on Cells and Viruses","volume":"13","author":"Zhao","year":"2022","journal-title":"mBio"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jolly, C., Welsch, S., Michor, S., and Sattentau, Q.J. (2011). The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002226"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/viro.1994.1531","article-title":"Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences","volume":"204","author":"Li","year":"1994","journal-title":"Virology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/jvi.65.4.2047-2055.1991","article-title":"Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein","volume":"65","author":"Earl","year":"1991","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"14947","DOI":"10.1073\/pnas.0602941103","article-title":"Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions","volume":"103","author":"Camus","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11742","DOI":"10.1128\/JVI.79.18.11742-11751.2005","article-title":"Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus","volume":"79","author":"Murray","year":"2005","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Muranyi, W., Malkusch, S., M\u00fcller, B., Heilemann, M., and Kr\u00e4usslich, H.G. (2013). Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003198"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/JVI.74.7.3264-3272.2000","article-title":"Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts","volume":"74","year":"2000","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1128\/JVI.00163-09","article-title":"Formation of syncytia is repressed by tetraspanins in human immunodeficiency virus type 1-producing cells","volume":"83","author":"Weng","year":"2009","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41467-018-04220-w","article-title":"Single molecule fate of HIV-1 envelope reveals late-stage viral lattice incorporation","volume":"9","author":"Buttler","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wang, L., Sandmeyer, A., H\u00fcbner, W., Li, H., Huser, T., and Chen, B.K. (2021). A Replication-Competent HIV Clone Carrying GFP-Env Reveals Rapid Env Recycling at the HIV-1 T Cell Virological Synapse. Viruses, 14.","DOI":"10.3390\/v14010038"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Lerner, G., Ding, L., Candor, K., and Spearman, P. (2023). Incorporation of the HIV-1 envelope glycoprotein into viral particles is regulated by the tubular recycling endosome in a cell type-specific manner. bioRxiv.","DOI":"10.1101\/2023.12.17.572063"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0854.2010.01036.x","article-title":"TIP47 is required for the production of infectious HIV-1 particles from primary macrophages","volume":"11","author":"Bauby","year":"2010","journal-title":"Traffic"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.str.2017.09.010","article-title":"Solution Structure and Membrane Interaction of the Cytoplasmic Tail of HIV-1 gp41 Protein","volume":"25","author":"Murphy","year":"2017","journal-title":"Structure"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bpj.2013.06.042","article-title":"Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein","volume":"105","author":"Boscia","year":"2013","journal-title":"Biophys. J."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Steckbeck, J.D., Sun, C., Sturgeon, T.J., and Montelaro, R.C. (2010). Topology of the C-terminal tail of HIV-1 gp41: Differential exposure of the Kennedy epitope on cell and viral membranes. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015261"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bbamem.2007.12.023","article-title":"Biophysical characterization and membrane interaction of the most membranotropic region of the HIV-1 gp41 endodomain","volume":"1778","author":"Moreno","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/s41467-020-16165-0","article-title":"Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein","volume":"11","author":"Piai","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1021\/jacs.1c01762","article-title":"NMR Model of the Entire Membrane-Interacting Region of the HIV-1 Fusion Protein and Its Perturbation of Membrane Morphology","volume":"143","author":"Piai","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/vir.0.18630-0","article-title":"A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: Evidence for its exposure on the surface of the virion","volume":"84","author":"Cleveland","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1743-422X-4-123","article-title":"Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein","volume":"4","author":"Costin","year":"2007","journal-title":"Virol. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bpj.2018.05.022","article-title":"HIV-1 Env gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Water, and Ion Interactions","volume":"115","author":"Hollingsworth","year":"2018","journal-title":"Biophys. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"45347","DOI":"10.1021\/jacs.5c15421","article-title":"Structural Heterogeneity of the Membrane-Interacting Region of the HIV-1 Envelope Glycoprotein","volume":"147","author":"Majumder","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e02105-24","DOI":"10.1128\/jvi.02105-24","article-title":"A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag lattice trapping and incorporation","volume":"99","author":"Hikichi","year":"2025","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/jvi.70.1.341-351.1996","article-title":"Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions","volume":"70","author":"Freed","year":"1996","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.282.5392.1327","article-title":"A structural explanation for the recognition of tyrosine-based endocytotic signals","volume":"282","author":"Owen","year":"1998","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/JVI.76.6.2683-2691.2002","article-title":"Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein","volume":"76","author":"Edwards","year":"2002","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e02219-16","DOI":"10.1128\/JVI.02219-16","article-title":"Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors","volume":"91","author":"Pacheco","year":"2017","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"12231","DOI":"10.1128\/JVI.79.19.12231-12241.2005","article-title":"Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail","volume":"79","author":"Wyss","year":"2005","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1245625","article-title":"Crystal structure of a soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Julien","year":"2013","journal-title":"Science"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.aad2450","article-title":"Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer","volume":"351","author":"Lee","year":"2016","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1038\/s41467-018-06121-4","article-title":"Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer","volume":"9","author":"Cao","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1245627","article-title":"Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Lyumkis","year":"2013","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s42003-023-04916-w","article-title":"Asymmetric conformations of cleaved HIV-1 envelope glycoprotein trimers in styrene-maleic acid lipid nanoparticles","volume":"6","author":"Wang","year":"2023","journal-title":"Commun. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Torrents de la Pe\u00f1a, A., Rantalainen, K., Cottrell, C.A., Allen, J.D., van Gils, M.J., Torres, J.L., Crispin, M., Sanders, R.W., and Ward, A.B. (2019). Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007920"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/JVI.74.2.627-643.2000","article-title":"A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure","volume":"74","author":"Binley","year":"2000","journal-title":"J. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1128\/JVI.76.17.8875-8889.2002","article-title":"Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1","volume":"76","author":"Sanders","year":"2002","journal-title":"J. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes","volume":"163","author":"Ozorowski","year":"2015","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.1128\/JVI.01653-15","article-title":"Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity","volume":"89","author":"Hu","year":"2015","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Klasse, P.J., LaBranche, C.C., Ketas, T.J., Ozorowski, G., Cupo, A., Pugach, P., Ringe, R.P., Golabek, M., van Gils, M.J., and Guttman, M. (2016). Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005864"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches","volume":"46","author":"Pauthner","year":"2017","journal-title":"Immunity"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"aac4223","DOI":"10.1126\/science.aac4223","article-title":"HIV-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"Sanders","year":"2015","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Klasse, P.J., Ketas, T.J., Cottrell, C.A., Ozorowski, G., Debnath, G., Camara, D., Francomano, E., Pugach, P., Ringe, R.P., and LaBranche, C.C. (2018). Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006913"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.celrep.2016.07.074","article-title":"Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies","volume":"16","author":"McCoy","year":"2016","journal-title":"Cell Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1426232","DOI":"10.3389\/fimmu.2024.1426232","article-title":"MRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies","volume":"15","author":"Guenaga","year":"2024","journal-title":"Front. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"eady6831","DOI":"10.1126\/scitranslmed.ady6831","article-title":"Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial","volume":"17","author":"Parks","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"eadw0721","DOI":"10.1126\/scitranslmed.adw0721","article-title":"Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models","volume":"17","author":"Cottrell","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e20250693","DOI":"10.1084\/jem.20250693","article-title":"Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes","volume":"222","author":"Gristick","year":"2025","journal-title":"J. Exp. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.celrep.2015.05.017","article-title":"Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers","volume":"11","author":"Pritchard","year":"2015","journal-title":"Cell Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e00592-23","DOI":"10.1128\/jvi.00592-23","article-title":"Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation","volume":"97","author":"Zhang","year":"2023","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tim.2020.03.007","article-title":"The Conformational States of the HIV-1 Envelope Glycoproteins","volume":"28","author":"Wang","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1038\/s41467-024-51656-4","article-title":"Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted\/founder sensitivity to broadly neutralizing antibodies","volume":"15","author":"Parthasarathy","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/aid.1990.6.371","article-title":"Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1","volume":"6","author":"Kalyanaraman","year":"1990","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"McCoy, L.E., Falkowska, E., Doores, K.J., Le, K., Sok, D., van Gils, M.J., Euler, Z., Burger, J.A., Seaman, M.S., and Sanders, R.W. (2015). Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005110"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"115331","DOI":"10.1016\/j.celrep.2025.115331","article-title":"Molecular parameters governing antibody Fc\u03b3R signaling and effector functions in the context of HIV envelope","volume":"44","author":"Bick","year":"2025","journal-title":"Cell Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41591-018-0186-4","article-title":"Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals","volume":"24","author":"Gruell","year":"2018","journal-title":"Nat. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-04797-9","article-title":"Combination anti-HIV antibodies provide sustained virological suppression","volume":"606","author":"Sneller","year":"2022","journal-title":"Nature"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1172\/JCI135557","article-title":"Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies","volume":"130","author":"Tuyishime","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41590-023-01741-5","article-title":"Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells","volume":"25","author":"Board","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1038\/s41598-017-07966-3","article-title":"One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fimmu.2020.00713","article-title":"Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART\u00ae Molecules","volume":"11","author":"Pollara","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/QAD.0000000000002543","article-title":"Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection","volume":"34","author":"Ramadoss","year":"2020","journal-title":"Aids"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.str.2008.09.005","article-title":"Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120","volume":"16","author":"Madani","year":"2008","journal-title":"Structure"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"10973","DOI":"10.1021\/bi061193r","article-title":"Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120","volume":"45","author":"Madani","year":"2006","journal-title":"Biochemistry"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1128\/JVI.00227-10","article-title":"Enhanced exposure of human immunodeficiency virus type 1 primary isolate neutralization epitopes through binding of CD4 mimetic compounds","volume":"84","author":"Yoshimura","year":"2010","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e2222073120","DOI":"10.1073\/pnas.2222073120","article-title":"Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity","volume":"120","author":"Fritschi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e01016-24","DOI":"10.1128\/jvi.01016-24","article-title":"The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity","volume":"98","author":"Marchitto","year":"2024","journal-title":"J. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.chom.2021.04.014","article-title":"Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir","volume":"29","author":"Rajashekar","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/prot.24726","article-title":"Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action","volume":"83","author":"Langley","year":"2015","journal-title":"Proteins"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1021\/acs.jmedchem.7b01337","article-title":"Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir","volume":"61","author":"Meanwell","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/nchembio.2460","article-title":"Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529","volume":"13","author":"Pancera","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1902493","article-title":"Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection","volume":"382","author":"Kozal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/QAD.0000000000002851","article-title":"Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1","volume":"35","author":"Ackerman","year":"2021","journal-title":"Aids"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1394644","DOI":"10.3389\/fimmu.2024.1394644","article-title":"Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study","volume":"15","author":"Llibre","year":"2024","journal-title":"Front. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chembiol.2023.03.003","article-title":"Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120","volume":"30","author":"Richard","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/jiaf461","article-title":"Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV","volume":"233","author":"Benlarbi","year":"2026","journal-title":"J. Infect. Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e0226724","DOI":"10.1128\/jvi.02267-24","article-title":"A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120","volume":"99","author":"Chatterjee","year":"2025","journal-title":"J. Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/811\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:40:59Z","timestamp":1784878859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":131,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["v18080811"],"URL":"https:\/\/doi.org\/10.3390\/v18080811","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}